The Growth Path Guru
Long/short equity

Iridex - In The Early Innings Of Margin Expansion

Iridex Corporation (NASDAQ:IRIX) Overview

Iridex is a medical device manufacturer that provides laser systems, delivery devices, consumables, and services to the ophthalmology market. Iridex has a market cap of $82.57 MM (based on closing price of 8.43 on 11/5/2013). Iridex reported strong quarterly earnings after the market close on 10/31/13. Revenues increased by 21% and net income moved into the black, going from a loss of $0.06/share to a gain of $0.05/share. The stock has jumped up since the earnings release, increasing from $5.97 at the close on 10/31 to $8.43 at the close on 11/5, for a total of gain of 41.2%.

Iridex's systems provide laser therapies to treat sight-threatening eye diseases. The two major types of

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details